MammoMARK Biopsy Site Identifier

https://youtu.be/t7NdJ-PMec4

MammoMARK® and CorMARK®
Biopsy Site Identifiers

Rapidly expanding collagen carrier anchors the marker in place for unsurpassed placement accuracy.1

Request Information

Product Support

Why Collagen?

What Clinicians are Saying:

“The most significant advantage we found with the MammoMARK® is the ability to consistently localize [it] using sonography.”

Krakos et al. Advantages of Using the New MammoMark® Percutaneous Breast Biopsy Marker – a Large Center Experience.

Interested in Learning More?

Contact us to learn how the MammoMARK® and CorMARK® markers can help benefit your practice.

2364

Additional Resources

Frequently Asked Questions

What is the difference between the MammoMARK® and CorMARK® markers?
The applicators are the only difference between the two markers. The CorMARK® markers are the direct puncture applicators and the MammoMARK® markers encompass all others.
What is the duration of the MammoMARK® and CorMARK® markers enhanced ultrasound visibility?
The collagen carrier appears hyperechoic on ultrasound, providing visibility for 6 to 8 weeks.1
Can I use the MammoMARK® marker with my non-Mammotome breast biopsy device?
Mammotome offers applicators for the MammoMARK® marker compatible with leading breast biopsy devices for U/S, stereotactic, and MRI-guided biopsies. Download our non-Mammotome biopsy device compatibility guide here.
Do the MammoMARK® and CorMARK® markers contain any nickel?
No, the MammoMARK® and CorMARK® markers do not contain any nickel. The markers are composed of bovine collagen and titanium.

See the rapid expansion of the MammoMARK® marker

https://youtu.be/t7NdJ-PMec4
Watch the video to see the rapid expansion of the MammoMARK marker

Would you like more information about Mammotome® Markers?

Contact Us

1. Corsi, F., Sorrentino, L., Sartani, A., Bossi, D., Amadori, R., Nebuloni, M., Truffi, M., Bonzini, M., & Foschi, D. (2015). Localization of nonpalpable breast lesions with sonographically visible clip: Optimizing tailored resection and clear margins.The American Journal of Surgery, 209(6), 950-95
2. MammoMARK® Device Test - PRC043442 Rev B, pgs. 2, 5-6: Collagen Expansion
3. Rosen EL, Baker JA, Soo MS. Accuracy of a collagen-plug biopsy site marking device deployed after stereotactic core needle breast biopsy. AJR Am J Roentgenol. 2003 Nov;181(5):1295-9. doi: 10.2214/ajr.181.5.1811295. PMID: 14573422.
4. Pinkney DM, Mychajlowycz M, Shah BA. A prospective comparative study to evaluate the displacement of four commercially available breast biopsy markers. Br J Radiol 2016; 89: 20160149. Page 4, middle right
5. Taghreed I Alshafeiy, Alison Matich, Carrie M Rochman, Jennifer A Harvey, Advantages and Challenges of Using Breast Biopsy Markers, Journal of Breast Imaging, Volume 4, Issue 1, January/February 2022, Pages 78–95, https://doi.org/10.1093/jbi/wbab052
6. Corsi F, Sorrentino L, Bossi D, Sartani A, Foschi D. Preoperative localization and surgical margins in conservative breast surgery. Int J Surg Oncol. 2013;2013:793819. doi:10.1155/2013/793819
7. HydroMARK™ Plus Device Test - PCR-000299, SDR0098 Vacuum Suction Testing
8. HydroMARK™ Plus Device Test - PCR-000414, Summative Usability
9. HydroMARK™ Design Plan – ADD-00013 Rev G, Page 15
10. Indication may not be approved or available in your region. Please check with your local Mammotome representative.
11. LumiMARK™ Device Tests: PCR-000340 System Design, PCR-000579 Summative Usability, ES-002647 Claims Assessment

MammoMARK® marker modality photos courtesy of Dr. Kimberly C. Hutcherson, North Metropolitan Radiology Associates, LLP

Products may not be approved or available in your region. Please check with your local Mammotome representative.